Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Fuentes Nathen — Putnam Hills Corp. insider: 1 transactions · InsiderLens

Home / Insiders / Fuentes Nathen

Fuentes Nathen

Chief Financial Officer at Telomir Pharmaceuticals, Inc. · on record since Feb 8, 2024
Chief Financial Officer at Putnam Hills Corp. · on record since Feb 25, 2025

Insider trading activity of Fuentes Nathen

Transactions on record: 1; since Feb 25, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 25, 2025

Figures computed from official regulatory filings — methodology.

Companies where Fuentes Nathen has traded

Putnam Hills Corp.1 tx · Feb 25, 2025

Track record of Fuentes Nathen

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Fuentes Nathen

Co-insiders of Fuentes Nathen

Abildgaard OlePutnam Hills Corp.
Alton Gregg HPutnam Hills Corp.
Aminov ErezTelomir Pharmaceuticals, Inc.
Bay Shore TrustTelomir Pharmaceuticals, Inc.
Binette FrancoisPutnam Hills Corp.
Boeren LeniPutnam Hills Corp.
Brink KarenPutnam Hills Corp.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Brosgart Carol LPutnam Hills Corp.

Calder Douglas WPutnam Hills Corp.

Chapman Christopher C JRTelomir Pharmaceuticals, Inc.

Christensen Torben BjornPutnam Hills Corp.

Collins Mark AnthonyPutnam Hills Corp.

D An EvelynPutnam Hills Corp.

Debruyne LucPutnam Hills Corp.

Degn LonePutnam Hills Corp.

Del Giudice Matthew PaulTelomir Pharmaceuticals, Inc.

Dybul MarkPutnam Hills Corp.

EAGLE CRAIGTelomir Pharmaceuticals, Inc.

Gronfeldt-Sorensen HenrikPutnam Hills Corp.

Gumrukcu SerhatPutnam Hills Corp.

Hendriks RuudPutnam Hills Corp.

Jerman Michael AllenTelomir Pharmaceuticals, Inc.

Kroenig BradleyTelomir Pharmaceuticals, Inc.

Leire, Eric Jean MariePutnam Hills Corp.

LOW NATHAN APutnam Hills Corp.

MacPherson Edward CloustonTelomir Pharmaceuticals, Inc.

MASRI SAMIR NAJIPutnam Hills Corp.

Masri Sasha SPutnam Hills Corp.

McColl Hugh IIITelomir Pharmaceuticals, Inc.

McNicol JaynePutnam Hills Corp.

McNulty Brian PatrickTelomir Pharmaceuticals, Inc.

MCNULTY JAMES APutnam Hills Corp.

Miller AvramPutnam Hills Corp.

MIRA PHARMACEUTICALS, INC.Telomir Pharmaceuticals, Inc.

Mushak AndriyTelomir Pharmaceuticals, Inc.

NATHAN LOW 2008 IRREVOCABLE TRUSTPutnam Hills Corp.

Nicholoudis ChristosTelomir Pharmaceuticals, Inc.

Nielsen, Niels ErikPutnam Hills Corp.

NLBDIT 2010 SERVICES, LLCPutnam Hills Corp.

PETERSEN ALDOPutnam Hills Corp.

Puche LuisaPutnam Hills Corp.

Rosenberg, JacobPutnam Hills Corp.

Sandler Carl Forest JrPutnam Hills Corp.

SAPIRSTEIN JAMESPutnam Hills Corp.

Sindlev RenePutnam Hills Corp.

Tarsh SimonPutnam Hills Corp.

Tuck TalhiaTelomir Pharmaceuticals, Inc.

van Tilburg MauricePutnam Hills Corp.

Weichselbaum AlanTelomir Pharmaceuticals, Inc.

Weinstein David HershelPutnam Hills Corp.

Company	Filed	Type	Qty	Price	Value · USD	Src
Putnam Hills Corp.	Feb 25, 2025	AwardD	250,000	0.00 USD	$0	SEC